STTCOMP MEB FA LONG
Medibio Ltd
Market cap - around $17m
Medibio is a medical technology company developing tests to assist in the diagnosis of depression, other mental health disorders and chronic stress. I liked today's announcement about the global agreement with Compass Group for ilumen which is a corporate wellness product. However, the main catalyst for me is the FDA approval for MEB-001 which is a device to assist in the diagnosis of depression. It is due around November 30 according to the AGM presentation announcement. Bit of a binary event - approval could see the share price fly whereas denial would see a big hit to the share price (obviously).
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 23 Nov
Short Term Trading Week Starting: 23 Nov, page-29
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online